Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 24, 2014
- Revision received August 4, 2014
- Accepted August 7, 2014
- Published online November 14, 2014.
Copyright & License
Copyright © 2014 The Author(s). Published by the International Institute of Anticancer Research.
Author Information
- 1Melanoma and Sarcoma Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy
- 2Melanoma and Sarcoma Unit, Veneto Institute of Oncology, IOV-IRCCS and Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
- 3Dermatology Unit, University of Padova, Padova, Italy
- Correspondence to: Marco Rastrelli, Melanoma and Sarcoma Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy. Tel: +39 498212137, Fax: +39 498218349, e-mail: marco.rastrelli{at}ioveneto.it
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Comparative Analysis of the Effect of the BRAF Inhibitor Dabrafenib in 2D and 3D Cell Culture Models of Human Metastatic Melanoma Cells
- Molecular Genomic Insights into Melanoma Associated Proteins PRAME and BAP1
- Overdiagnosis in malignant melanoma: a scoping review
- Incident skin melanoma in Danish male military pilots: a nested case-control study
- Incident skin melanoma in Danish male military pilots: a nested case-control study
- Incidence and mortality of uveal melanoma in Australia (1982-2014)
- 3D melanoma spheroid model for the development of positronium biomarker
- Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired Resistance via Inhibition of RAF Dimerization in PLX4032-resistant Melanoma
- GBP2 Is a Favorable Prognostic Marker of Skin Cutaneous Melanoma and Affects Its Progression via the Wnt/{beta}-catenin Pathway
- Melanoma Risk Estimation Based on Objective Measures as a Complement to Self-Assessment
- Residual Tumor on Wide Excisional Margins After Treatment of Invasive Melanoma
- Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
- All-trans Retinoic Acid Overcomes Acquired Resistance to PLX4032 via Inhibition of PIN1 in Melanoma Cells
- Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system
- MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas
- Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of PFKFB4 Overexpression for Disease Progression
- Karnofsky Performance Score, Radiation Dose and Nodal Status Predict Survival of Elderly Patients Irradiated for Limited-disease Small-cell Lung Cancer
- Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients
- Analysis of the Antitumor Activity of Clotrimazole on A375 Human Melanoma Cells